Monoclonal antibody 2F5Alternative Names: IAM-41-2F5; MAb 2F5
Latest Information Update: 15 Aug 2002
At a glance
- Originator Unknown
- Class Amino acids; Antivirals; Monoclonal antibodies
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 12 Oct 1995 Preclinical development for HIV-1 infections (Unknown route)